It has been widely reported that tumor-derived TGF-β could be the soluble factor responsible for the decreased NKG2D expression on NK cells and/or CD8+ T cells observed in several types of tumor patients [30,37,38,39,40,41,42]. Here, TGFB1 is linked to neoplasm.